- Home
- BBIO vs DTM Comparison
BBIO vs DTM Comparison
Compare BBIO & DTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- DTM
- Stock Information
- Founded
- BBIO 2015
- DTM 2021
- Country
- BBIO United States
- DTM United States
- Employees
- BBIO N/A
- DTM N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- DTM Oil & Gas Production
- Sector
- BBIO Health Care
- DTM Utilities
- Exchange
- BBIO Nasdaq
- DTM Nasdaq
- Market Cap
- BBIO 10.4B
- DTM 11.1B
- IPO Year
- BBIO 2019
- DTM N/A
- Fundamental
- Price
- BBIO $61.73
- DTM $113.36
- Analyst Decision
- BBIO Strong Buy
- DTM Buy
- Analyst Count
- BBIO 18
- DTM 12
- Target Price
- BBIO $74.28
- DTM $116.50
- AVG Volume (30 Days)
- BBIO 2.7M
- DTM 862.0K
- Earning Date
- BBIO 10-29-2025
- DTM 10-30-2025
- Dividend Yield
- BBIO N/A
- DTM 2.88%
- EPS Growth
- BBIO N/A
- DTM N/A
- EPS
- BBIO N/A
- DTM 3.96
- Revenue
- BBIO $353,780,000.00
- DTM $1,175,000,000.00
- Revenue This Year
- BBIO $123.32
- DTM $27.01
- Revenue Next Year
- BBIO $73.46
- DTM $8.91
- P/E Ratio
- BBIO N/A
- DTM $28.72
- Revenue Growth
- BBIO 62.46
- DTM 20.39
- 52 Week Low
- BBIO $21.72
- DTM $83.30
- 52 Week High
- BBIO $69.48
- DTM $115.80
- Technical
- Relative Strength Index (RSI)
- BBIO 59.65
- DTM 62.08
- Support Level
- BBIO $60.23
- DTM $109.12
- Resistance Level
- BBIO $64.44
- DTM $112.42
- Average True Range (ATR)
- BBIO 3.05
- DTM 2.80
- MACD
- BBIO 0.06
- DTM 0.47
- Stochastic Oscillator
- BBIO 53.68
- DTM 96.81
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About DTM DT Midstream Inc.
DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.